Видео ютуба по тегу Azurrx

James Sapirstein, President and CEO at AzurRx BioPharma
James Sapirstein, President and CEO at AzurRx BioPharma
Thjis Spoor from AzurRx Biopharma on CEO Money
Thjis Spoor from AzurRx Biopharma on CEO Money
WRSR: Релизная Республика, часть 249 - Дороги, тропинки, электричество в Рельсовске
WRSR: Релизная Республика, часть 249 - Дороги, тропинки, электричество в Рельсовске
Azurrx BioPharma: a clinical stage biopharmaceutical company
Azurrx BioPharma: a clinical stage biopharmaceutical company
AzurRX (AZRX) recap of 2016 company highlights
AzurRX (AZRX) recap of 2016 company highlights
FMW Media - AzurRx BioPharma
FMW Media - AzurRx BioPharma
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx BioPharma, Inc. (NASDAQ: AZRX)
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
AzurRx Cultivates Therapeutic Proteins for GI Disorder Treatment
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
AzurRx CEO James Sapirstein discusses the Company's recently licensed niclosamide asset
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
AzurRx's (AZRX) CEO Thijs Spoor - Investors can expect upcoming news about Phase 2 trial results
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
AzurRx BioPharma, Inc. (NASDAQ: AZRX) Webcast | SNN Network
The Richmond Club Stock Pick - AzurRx Biopharma #shorts
The Richmond Club Stock Pick - AzurRx Biopharma #shorts
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.
James Sapirstein, CEO of AzurRx BioPharma, Inc. talks about AZRX’s products and therapies.
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
AzurRx Biopharma Ceo Discusses Covid Variants, What He Is Excited About, Company Strategy! $AZRX
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
AzurRx BioPharma Describes Phase 2 Clinical Trial for Cystic Fibrosis and Value Catalysts
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx BioPharma (NASDAQ: AZRX) | James Sapirstein, President & CEO | Innovators with Jane King
AzurRx BioPharma Presentation at Investor Summit Group’s Q2 Virtual Investor Summit
AzurRx BioPharma Presentation at Investor Summit Group’s Q2 Virtual Investor Summit
Thijs Spoor of AzurRx Provides a Company Overview
Thijs Spoor of AzurRx Provides a Company Overview
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
AzurRX Biopharma (NASDAQ: AZRX): Next Generation Targeted GI Therapies
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index
AzurRx: the latest stock pick for the 16.5% per year high growth Richmond Club Index